ufiprazole structure
|
Common Name | ufiprazole | ||
|---|---|---|---|---|
| CAS Number | 73590-85-9 | Molecular Weight | 329.417 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 539.7±60.0 °C at 760 mmHg | |
| Molecular Formula | C17H19N3O2S | Melting Point | 124 °C | |
| MSDS | Chinese USA | Flash Point | 280.2±32.9 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of ufiprazoleOmeprazole sulfide is a metabolite of Omeprazole, which is a proton pump inhibitor. |
| Name | 6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfanyl]-1H-benzimidazole |
|---|---|
| Synonym | More Synonyms |
| Description | Omeprazole sulfide is a metabolite of Omeprazole, which is a proton pump inhibitor. |
|---|---|
| Related Catalog |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 539.7±60.0 °C at 760 mmHg |
| Melting Point | 124 °C |
| Molecular Formula | C17H19N3O2S |
| Molecular Weight | 329.417 |
| Flash Point | 280.2±32.9 °C |
| Exact Mass | 329.119812 |
| PSA | 85.33000 |
| LogP | 3.87 |
| Vapour Pressure | 0.0±1.4 mmHg at 25°C |
| Index of Refraction | 1.649 |
| Storage condition | -20°C Freezer |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Phrases | 36/37/38 |
| Safety Phrases | 26 |
| RIDADR | NONH for all modes of transport |
| HS Code | 2933990090 |
|
~84%
ufiprazole CAS#:73590-85-9 |
| Literature: Kuraray Co., Ltd. Patent: US6197962 B1, 2001 ; |
|
~91%
ufiprazole CAS#:73590-85-9 |
| Literature: ORCHID CHEMICALS and PHARMACEUTICALS LTD; REGURI, Buchi Reddy; UPPARAPALLI, Sampathkumar; SIVADAS, Anand; VIGNESWARA CHELLAM, Ravisankar; SHANMUGA SUNDARAM, Bharani Kumar; SUBBAIAH, Ramesh Patent: WO2011/12957 A1, 2011 ; Location in patent: Page/Page column 16 ; |
|
~%
ufiprazole CAS#:73590-85-9 |
| Literature: US2007/82929 A1, ; Page/Page column 42 ; US 20070082929 A1 |
|
~%
ufiprazole CAS#:73590-85-9 |
| Literature: WO2004/35565 A1, ; Page 5; 8-9 ; |
|
~77%
ufiprazole CAS#:73590-85-9 |
| Literature: Cipla Limited Patent: EP1085019 A1, 2001 ; |
|
~93%
ufiprazole CAS#:73590-85-9 |
| Literature: Kuraray Co., Ltd. Patent: US6350876 B2, 2002 ; Location in patent: Example 23 ; |
|
~87%
ufiprazole CAS#:73590-85-9 |
| Literature: Kuraray Co., Ltd. Patent: US6350876 B2, 2002 ; Location in patent: Example 22 ; |
|
~%
ufiprazole CAS#:73590-85-9 |
| Literature: Synthetic Communications, , vol. 32, # 8 p. 1211 - 1217 |
|
~%
ufiprazole CAS#:73590-85-9 |
| Literature: Rane; Pathak; Kaushik; Prasad Rao; Kumar, Ashok Synthetic Communications, 2002 , vol. 32, # 8 p. 1211 - 1217 |
| Precursor 10 | |
|---|---|
| DownStream 4 | |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| Omeprazole sulfide |
| 5-METHOXY-2-[((4-METHOXY-3,5 |
| Ufiprazol |
| 5-Methoxy-2-(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl thio-1H-benzimidazole; (Intermediate of Omeprazole) |
| Pyrmetazole |
| 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]thio]-1H-benzimidazole |
| EINECS 208-591-9 |
| MFCD00869021 |
| 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methyl]thio]benzimidazole |
| omeprazole sulphide |
| 5-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylthio]-1H-benzimidazole |
| 5-METHOXY-2-((3,5-DIMETHYL-4-METHOXY-2-PYRIDINYL)-METHYLTHIO)-1H-BENZIMIDAZOLE |
| ufiprazole |
| Ufiprazolum |
| 5-Methoxy-2-{[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfanyl}-1H-benzimidazole |
| 2-{[(3,5-dimethyl-4-methoxy-2-pyridinyl)-methyl]-thio}-5-methoxy-1h-benzimidazole |
| 6-Methoxy-2-{[(4-Methoxy-3,5-Dimethylpyridin-2-Yl)methyl]sulfanyl}-1h-Benzimidazole |
| 1H-Benzimidazole, 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]thio]- |
| 5-Methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfanyl}-1H-benzimidazole |
| Esomeprazole Impurity 3 |
| Omeprazole metabolite Omeprazole sulfide |